Vascular anomalies classification: Recommendations from the international society for the study of vascular anomalies

Pediatrics

Volumn 136, Issue 1, 2015, Pages e203-e214

  Wassef, Michel ^a   Blei, Francine ^b   Adams, Denise ^c   Alomari, Ahmad ^d   Baselga, Eulalia ^e   Berenstein, Alejandro ^f   Burrows, Patricia ^g   Frieden, Ilona J ^h   Garzon, Maria C ⁱ   Lopez Gutierrez, Juan Carlos ^j   Lord, David J E ^k   Mitchel, Sally ^l   Powell, Julie ^m   Prendiville, Julie ⁿ   Vikkula, Miikka ^o  

^a HÔPITAL LARIBOISIÈRE   (France)

^b LENOX HILL HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j HOSPITAL INFANTIL LA PAZ   (Spain)

^k SYDNEY CHILDREN'S HOSPITAL   (Australia)

^l JOHNS HOPKINS HOSPITAL   (United States)

^m UNIVERSITY OF MONTREAL   (Canada)

ⁿ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^o DE DUVE INSTITUTE   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTERIOVENOUS MALFORMATION; ARTICLE; CAPILLARY HEMANGIOMA; CAPILLARY MALFORMATION; CAVERNOUS HEMANGIOMA; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL DISORDER; CONGENITAL HEMANGIOMA; DISEASE CLASSIFICATION; HEMANGIOMA; HEREDITY; HUMAN; LYMPHATIC MALFORMATION; MACROCEPHALY; MICROANGIOPATHY; MICROCEPHALY; MULTIPLE CANCER; OSTEOCHONDROMA; PRIORITY JOURNAL; STURGE WEBER SYNDROME; VASCULAR TUMOR; CLASSIFICATION; MEDICAL RESEARCH; MEDICAL SOCIETY; PRACTICE GUIDELINE;

BIOMEDICAL RESEARCH; GUIDELINES AS TOPIC; HUMANS; SOCIETIES, MEDICAL; VASCULAR MALFORMATIONS;

EID: 84934294249     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-3673     Document Type: Article

References (58)

1. Hand JL, Frieden IJ. Vascular birthmarks of infancy: resolving nosologic confusion. Am J Med Genet. 2002;108(4):257-264
2. Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011;127(1): 347-351
3. Kollipara R, Dinneen L, Rentas KE, et al. Current classification and terminology of pediatric vascular anomalies. AJR Am J Roentgenol. 2013;201(5): 1124-1135
4. Mulligan PR, Prajapati HJ, Martin LG, Patel TH. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol. 2014;87(1035):20130392
5. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375-423
6. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol. 1997;24(11):701-710
7. Enjolras O, Wassef M, Chapot R. Color Atlas of Vascular Tumors and Vascular Malformations. Cambridge, United Kingdom: Cambridge University Press; 2007
8. Virchow R. Angioma in die Krankhaften Geschwülste. Berlin, Germany: Hirshwald; 1863:306-425
9. Wegener G. Ueber Lynmphangiome. Arch Klin Chir. 1877;20:641-707
10. Mulliken JB, Young AE. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, PA: Saunders; 1988
11. Sangueza OP, Kasper RC, LeBoit P, et al. Vascular tumors. In: LeBoit PE, Burg G, Weedon D, Sarasain A, eds. Pathology and Genetics of Skin Tumors: World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2006: 233-246
12. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. WHO Classification of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2013
13. Calonje JE. Hemangiomas. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. WHO Classification of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2013: 138-140
14. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69(3): 412-422
15. Lee BB, Baumgartner I, Berlien P, et al. Diagnosis and treatment of venous malformations consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol. 2015; 34(2):97-144
16. Godfraind C, Calicchio ML, Kozakewich H. Pyogenic granuloma, an impaired wound healing process, linked to vascular growth driven by FLT4 and the nitric oxide pathway. Mod Pathol. 2013;26(2): 247-255
17. Battocchio S, Facchetti F, Brisigotti M. Spindle cell haemangioendothelioma: further evidence against its proposed neoplastic nature. Histopathology. 1993; 22(3):296-298
18. Sun ZJ, Zhang L, Zhang WF, Liu B, Li ZB, Zhao YF. A possible hypoxia-induced endothelial proliferation in the pathogenesis of epithelioid hemangioma. Med Hypotheses. 2006;67(5):1133-1135
19. Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol. 1997;37(4):523-549; quiz 549-552
20. Requena L, Sangueza OP. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. 1997;37(6):887-919; quiz 920-882
21. Requena L, Sangueza OP. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. J Am Acad Dermatol. 1998;38(2 pt 1): 143-175; quiz 176-148
22. North PE, Waner M, Buckmiller L, James CA, Mihm MC Jr. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol. 2006;15 (6):303-317
23. Wassef M, Hunt SJ, Santa Cruz DJ, Barnhill RL. Vascular tumors and vascular malformations. In: Barnhill RL, Crowson AN, Magro CM, Piepkorn MW, eds. Dermatopathology. 3rd ed. New York, NY: McGraw-Hill; 2010:802-856
24. Kozakewich HPW, Mulliken JB. Histopathology of vascular malformations. In: Mulliken JB, Burrows PE, Fishman SJ, eds. Mulliken & Young's Vascular Anomalies, Hemangiomas and Malformations. 2nd ed. New York, NY: Oxford University Press; 2013: 480-507
25. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25(2): 168-173
26. Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161(2): 240-245
27. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol. 2004;50(6):875-882
28. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC Jr. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003;139(7):869-875
29. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996;132(3):307-311
30. Metry D, Heyer G, Hess C, et al; PHACE Syndrome Research Conference. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics. 2009;124(5):1447-1456
31. Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010;157(5): 795-801, e791
32. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31(1):11-22
33. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001; 137(5):559-570
34. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996; 128(3):329-335
35. Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003;6(6):495-510
36. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg. 2001;107(7): 1647-1654
37. Nasseri E, Piram M, McCuaig CC, Kokta V, Dubois J, Powell J. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 2014;70(1):75-79
38. Baselga E, Cordisco MR, Garzon M, Lee MT, Alomar A, Blei F. Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series. Br J Dermatol. 2008; 158(6):1363-1370
39. Osio A, Fraitag S, Hadj-Rabia S, Bodemer C, de Prost Y, Hamel-Teillac D. Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature. Arch Dermatol. 2010;146(7):758-763
40. Le Huu AR, Jokinen CH, Rubin BP, et al. Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol. 2010;34(11):1563-1573
41. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993;17(4):321-328
42. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr. 1997;130(4):631-640
43. Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100(6):1377-1386
44. Fishman SJ, Young AE. Slow-flow vascular malformations. In: Mulliken JB, Burrows PE, Fishman SJ, eds. Mulliken & Young's Vascular Anomalies, Hemangiomas and Malformations. 2nd ed. New York, NY: Oxford University Press; 2013:562-594
45. Vogel SA, Hess CP, Dowd CF, et al. Early versus later presentations of venous malformations: where and why? Pediatr Dermatol. 2013;30(5): 534-540
46. Vikkula M, Boon LM, Carraway KL III, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87(7): 1181-1190
47. Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol. 2013;4 (4):179-183
48. Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet. 2002;70(4):866-874
49. Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med. 2013; 19(5):302-308
50. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg. 1998; 102(3):643-654
51. McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med. 2011;13(7):607-616
52. Revencu N, Boon LM, Mendola A, et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat 2013;34(12): 1632-1641
53. Tennant LB, Mulliken JB, Perez-Atayde AR, Kozakewich HP. Verrucous hemangioma revisited. Pediatr Dermatol. 2006;23(3): 208-215
54. Mankani MH, Dufresne CR. Verrucous malformations: their presentation and management. Ann Plast Surg. 2000;45(1): 31-36
55. North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity. Arch Dermatol. 2004;140(5):599-606
56. Prasad V, Fishman SJ, Mulliken JB, et al. Cutaneovisceral angiomatosis with thrombocytopenia. Pediatr Dev Pathol. 2005;8(4):407-419
57. Rao VK, Weiss SW. Angiomatosis of soft tissue: an analysis of the histologic features and clinical outcome in 51 cases. Am J Surg Pathol. 1992;16(8): 764-771
58. Kurek KC, Howard E, Tennant LB, et al. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol. 2012; 36(5):671-687